Non-Standard Doses of Dasatinib Sustain Cytogenetic Response In Chronic Myeloid Leukemia (CML) Patients

Autor: Seguro, Fernanda Salles *, Serpa, Mariana Gomes *, de Andrade Silva, Marcela Cavalcante *, Steinbaum, Daniel Salas *, Pereira, Thales DM *, Xavier, Flavia Dias *, Barroso, Claudia Bitti *, Bendit, Israel *, Llacer, Pedro E Dorlhiac *
Zdroj: In Blood 19 November 2010 116(21):2285-2285
Databáze: ScienceDirect